V

    Veracyte Inc (VCYT)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $43.19
    -0.15 (-0.35%)

    Market Cap: $3.48B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    75%(30/40)
    Avg Surprise
    +76.23%
    Streak
    10 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.41
    Range$0.35 - $0.45
    11 analysts
    EPS RevisionsNo revisions (7d)
    0
    9
    30d
    EPS Estimate Drift
    90d ago$0.43+5.2%
    60d ago$0.43+4.9%
    30d ago$0.44+5.9%
    7d ago$0.41+0.0%
    Current$0.41
    Revenue Consensus
    $147M
    Range$145M - $149M
    10 analysts
    Dec 31, 2026
    EPS Consensus$0.73
    Range$0.60 - $0.81
    11 analysts
    Revenue Consensus
    $172M
    Range$168M - $176M
    12 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.73---
    Sep 26EST
    		-$0.41---
    Jun 26
    		$0.37$0.29+27.59%Beat-15.9%
    Mar 26
    		$0.52$0.33+57.58%Beat+67.7%
    Dec 25
    		$0.53$0.39+35.90%Beat+47.2%
    Sep 25
    		$0.51$0.32+59.38%Beat+54.5%
    Jun 25
    		$0.44$0.30+46.67%Beat+46.7%
    Mar 25
    		$0.31$0.20+55.00%Beat+675.0%
    Dec 24
    		$0.36$0.26+40.02%Beat+192.3%
    Sep 24
    		$0.33$0.17+94.12%Beat+180.5%
    Jun 24
    		$0.30$-0.01+3100.00%Beat+350.0%
    Mar 24
    		$0.04N/A+140.00%Beat+136.4%
    Dec 23
    		$-0.39$-0.09-333.33%Miss-680.0%
    Sep 23
    		$-0.41$-0.13-215.38%Miss-241.7%
    Jun 23
    		$-0.12$-0.14+14.29%Beat+7.7%
    Mar 23
    		$-0.11$-0.11+0.00%Beat+45.0%
    Dec 22
    		$-0.05N/A+66.67%Beat+66.7%
    Sep 22
    		$-0.12$-0.23+47.83%Beat+40.0%
    Jun 22
    		$-0.13$-0.22+40.91%Beat+0.0%
    Mar 22
    		$-0.20$-0.23+13.04%Beat+69.7%
    Dec 21
    		$-0.15$-0.16+6.25%Beat-7.1%
    Sep 21
    		$-0.20$-0.14-42.86%Miss-150.0%
    Jun 21
    		$-0.13$-0.25+48.00%Beat+40.9%
    Mar 21
    		$-0.66$-0.12-450.00%Miss-175.0%
    Dec 20
    		$-0.14$-0.10-40.00%Miss+6.7%
    Sep 20
    		$-0.08N/A+57.89%Beat-300.0%
    Jun 20
    		$-0.22$-0.27+18.52%Beat-340.0%
    Mar 20
    		$-0.24$-0.20-20.00%Miss-380.0%
    Dec 19
    		$-0.15$-0.07-114.29%Miss-87.5%
    Sep 19
    		$-0.02N/A+71.43%Beat+83.3%
    Jun 19
    		$-0.05$-0.09+44.44%Beat+72.2%
    Mar 19
    		$-0.05$-0.07+28.57%Beat+81.5%
    Dec 18
    		$-0.08$-0.15+46.67%Beat+66.7%
    Sep 18
    		$-0.12$-0.21+42.86%Beat+42.9%
    Jun 18
    		$-0.18$-0.26+30.77%Beat+18.2%
    Mar 18
    		$-0.27$-0.25-8.00%Miss-12.5%
    Dec 17
    		$-0.24$-0.20-20.00%Miss-71.4%
    Sep 17
    		$-0.21$-0.21+0.00%Beat-5.0%
    Jun 17
    		$-0.22$-0.25+12.00%Beat-
    Mar 17
    		$-0.24$-0.23-4.35%Miss-
    Dec 16
    		$-0.14$-0.26+46.15%Beat-
    Sep 16
    		$-0.20$-0.21+4.76%Beat-

    Key Metrics

    Valuation
    P/E Ratio22.38EV/EBITDA23.33x
    Price/FCF20.81xFCF Yield4.81%
    Profitability
    Profit Margin20.40%Operating Margin15.30%
    ROE8.77%ROIC8.24%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio9.16xQuick Ratio8.80x
    Trading Statistics
    Beta1.94Avg Volume1.32M
    52-Week High$60.9152-Week Low$29.38

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$42.85
    SMA 20$43.89
    SMA 50$51.64
    SMA 200$42.58
    EMA 10$43.57
    EMA 20$45.01
    EMA 50$47.54
    EMA 200$43.02

    MACD

    Line: -2.17Signal: -2.64Hist: 0.47

    ADX

    ADX: 31.1+DI: 16.5-DI: 29.6

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down68.0
    PSAR$40.42

    Bollinger Bands

    Upper Band$48.02
    Lower Band$39.76
    %B Position1882%(Upper)
    Band Width0.42

    RSI (14-Day)

    Neutral
    41.4

    Momentum Oscillators

    Stoch %K54.2
    Stoch %D56.2
    Williams %R-53.6
    ROC (10d)2.6%
    Momentum1.11
    CCI (20d)-44.0
    MFI (14d)51.6

    Volatility Measures

    ATR (14d)$2.25(5.2%)
    StdDev (20d)2.06
    Hist Vol46.6%(High)

    Volume Flow

    VWAP$42.71
    OBV-19.2M
    AD Line8.4M
    CMF (20d)0.099

    Volume Metrics

    Avg Vol (20d)1.3M
    Vol Ratio1.1x
    VWMA (20d)$43.70

    Pivot Points

    R3$47.05
    R2$46.30
    R1$44.82
    Pivot Point$44.07
    S1$42.59
    S2$41.84
    S3$40.36

    Advanced Oscillators

    TSI-22.08
    Ultimate Osc57.9
    KST-196.70

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$150.32M$139.07M$140.64M$131.87M$130.16M$114.47M$118.63M$115.86M$114.43M$96.84M$98.20M$90.11M
    Cost of Revenue$41.77M$37.91M$38.66M$40.59M$40.40M$34.97M$39.88M$36.85M$36.52M$34.38M$38.22M$32.42M
    Gross Profit$108.55M$101.16M$101.97M$91.28M$89.77M$79.51M$78.75M$79.01M$77.91M$62.47M$59.98M$57.69M
    Operating Expenses$88.31M$81.22M$67.48M$71.04M$97.70M$79.19M$77.39M$69.91M$76.22M$70.04M$104.33M$94.24M
    R&D$29.44M$27.10M$20.85M$15.98M$16.26M$17.72M$19.29M$17.57M$16.46M$15.96M$18.67M$13.32M
    SG&A$27.44M$23.68M$17.37M$27.28M$32.33M$33.81M$26.91M$25.74M$31.75M$26.21M$23.80M$16.33M
    Operating Income$22.98M$22.65M$37.20M$22.95M$-5,268,000$2.90M$4.17M$12.02M$4.61M$-4,656,000$-35,507,000$-31,739,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$4.06M$0$0$732,000$0$0$0$0$0
    Income Before Tax$26.52M$29.97M$40.63M$18.89M$1.25M$7.43M$3.44M$16.85M$7.36M$-1,908,000$-30,472,000$-29,772,000
    Income Tax Expense$1.03M$1.27M$-515,000$-248,000$2.23M$381,000$-1,670,000$1.69M$1.63M$-44,000$-2,179,000$-154,000
    Net Income$25.49M$28.71M$41.15M$19.14M$-980,000$7.05M$5.11M$15.15M$5.73M$-1,864,000$-28,293,000$-29,618,000
    EBITDA$30.64M$34.79M$45.28M$24.16M$5.69M$11.91M$9.34M$22.73M$13.10M$3.68M$-24,136,000$-22,449,000
    EBIT$26.52M$29.97M$40.63M$18.89M$1.25M$7.43M$3.44M$16.85M$7.36M$-1,908,000$-30,472,000$-29,772,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VCYT

    Government Contracts

    Gov Obligations (TTM)
    $3.52M
    Gov Obligations / Revenue
    0.6%
    Obligations YoY
    199.5%
    Active Awards
    46
    New Awards (TTM)
    24
    Avg Remaining Term
    9.3 mo

    Top agency: Department of Veterans Affairs at 89.7% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25726N0108Department of Veterans AffairsDepartment of Veterans Affairs$716112Jan 1, 2026
    36C24826F0044Department of Veterans AffairsDepartment of Veterans Affairs$324059Dec 1, 2025
    36C24126N0219Department of Veterans AffairsDepartment of Veterans Affairs$281000Feb 1, 2026
    75H71225F80098Department of Health and Human ServicesIndian Health Service$262760Sep 10, 2025
    36C24826N0322Department of Veterans AffairsDepartment of Veterans Affairs$194435Feb 1, 2026
    36C26326N0391Department of Veterans AffairsDepartment of Veterans Affairs$168000May 1, 2026
    36C25626N0188Department of Veterans AffairsDepartment of Veterans Affairs$165200Apr 1, 2026
    36C25026N0178Department of Veterans AffairsDepartment of Veterans Affairs$129624Nov 15, 2025
    36C26126F0025Department of Veterans AffairsDepartment of Veterans Affairs$129624Oct 1, 2025
    36C26326N0393Department of Veterans AffairsDepartment of Veterans Affairs$112200May 1, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    A Look at Veracyte Inc (VCYT) After 6.2% Gain -- GF Value $38.77 vs Price $44.08

    Veracyte Inc (VCYT) shares recently rose 6.2% to $44.08, but GuruFocus assesses the stock as "modestly overvalued" with a GF Value of $38.77. Despite a strong GF Score of 80/100, indicating good financial strength, growth, and momentum, its profitability is weak, and insiders have sold $21.2 million worth of shares with no purchases, signaling potential caution for investors.

    GuruFocus•8/26/26•
    Somewhat-Bearish

    Veracyte (VCYT) Receives a Buy from Piper Sandler

    Piper Sandler analyst David Westenberg maintained a Buy rating on Veracyte (VCYT) with a price target of $54.00, citing his 5-star analyst status and strong return average. Despite positive financial performance with increased quarterly revenue and net profit, corporate insider sentiment for VCYT is negative, with an increase in share selling over the past quarter. The overall Street consensus for Veracyte is a Moderate Buy with an average price target of $57.75.

    The Globe and Mail•8/25/26•
    Somewhat-Bullish

    VCYT Drops 25.3% in the Past Month. Is the Sell-Off an Opportunity?

    Veracyte, Inc. (VCYT) shares have dropped 25.3% in the past month despite strong Q2 2026 revenue and earnings growth. The article examines whether this sell-off presents a buying opportunity, considering the strong demand for core tests like Decipher and Afirma, new product launches, and positive analyst revisions against risks like reimbursement uncertainty and execution challenges. While the stock trades at a premium compared to its peers, a strong balance sheet and a Zacks Rank #1 (Strong Buy) suggest potential, tempered by valuation concerns.

    TradingView•8/25/26•
    Neutral

    Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $54

    Piper Sandler has reiterated its Buy rating for Veracyte (VCYT.US), maintaining a target price of $54. This indicates continued confidence in the company's financial prospects and stock performance.

    Moomoo•8/24/26•
    Bullish

    Virtus Advisers LLC Purchases New Shares in Veracyte, Inc. $VCYT

    Virtus Advisers LLC has acquired a new position in Veracyte, Inc. (NASDAQ:VCYT), purchasing 37,574 shares valued at approximately $2.2 million. Other institutional investors like BlackRock and First Trust Advisors also increased their holdings. This comes as Veracyte reported strong quarterly earnings, beating estimates with $0.54 EPS and 15.5% year-over-year revenue growth, despite some insider selling activities.

    MarketBeat•8/21/26•
    Somewhat-Bullish

    Frequently Asked Questions About VCYT

    Does VCYT pay dividends?
    Veracyte Inc (VCYT) does not currently pay a regular dividend.
    What is VCYT's P/E ratio?
    Veracyte Inc has a price-to-earnings (P/E) ratio of 22.38.
    What is VCYT's market cap?
    Veracyte Inc (VCYT) has a market capitalization of $3.48B with a current stock price of $43.19.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In